Given that ferroptosis requires both elevated iron levels and dampened ROS-neutralizing activities, these two studies compensate with each other in understanding the vulnerability of MYCN-amplified NB cells towards ferroptosis. The gene discussed is MYCN; the disease is neuroblastoma.